Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

Camille V. Edwards, Julia Gould, Arielle L. Langer, Markus Mapara, Jai Radhakrishnan, Mathew S. Maurer, Shahzad Raza, John G. Mears, Jonathan Wall, Alan Solomon, Suzanne Lentzsch

Research output: Contribution to journalLetter

18 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)58-59
Number of pages2
JournalAmyloid
Volume24
DOIs
StatePublished - Mar 16 2017

Fingerprint

Amyloidosis
Monoclonal Antibodies

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Edwards, C. V., Gould, J., Langer, A. L., Mapara, M., Radhakrishnan, J., Maurer, M. S., ... Lentzsch, S. (2017). Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis. Amyloid, 24, 58-59. https://doi.org/10.1080/13506129.2017.1292900

Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis. / Edwards, Camille V.; Gould, Julia; Langer, Arielle L.; Mapara, Markus; Radhakrishnan, Jai; Maurer, Mathew S.; Raza, Shahzad; Mears, John G.; Wall, Jonathan; Solomon, Alan; Lentzsch, Suzanne.

In: Amyloid, Vol. 24, 16.03.2017, p. 58-59.

Research output: Contribution to journalLetter

Edwards, CV, Gould, J, Langer, AL, Mapara, M, Radhakrishnan, J, Maurer, MS, Raza, S, Mears, JG, Wall, J, Solomon, A & Lentzsch, S 2017, 'Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis', Amyloid, vol. 24, pp. 58-59. https://doi.org/10.1080/13506129.2017.1292900
Edwards, Camille V. ; Gould, Julia ; Langer, Arielle L. ; Mapara, Markus ; Radhakrishnan, Jai ; Maurer, Mathew S. ; Raza, Shahzad ; Mears, John G. ; Wall, Jonathan ; Solomon, Alan ; Lentzsch, Suzanne. / Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis. In: Amyloid. 2017 ; Vol. 24. pp. 58-59.
@article{1b9995b7ba4a46abbf607c361dc503d2,
title = "Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis",
author = "Edwards, {Camille V.} and Julia Gould and Langer, {Arielle L.} and Markus Mapara and Jai Radhakrishnan and Maurer, {Mathew S.} and Shahzad Raza and Mears, {John G.} and Jonathan Wall and Alan Solomon and Suzanne Lentzsch",
year = "2017",
month = "3",
day = "16",
doi = "10.1080/13506129.2017.1292900",
language = "English (US)",
volume = "24",
pages = "58--59",
journal = "Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis",
issn = "1350-6129",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis

AU - Edwards, Camille V.

AU - Gould, Julia

AU - Langer, Arielle L.

AU - Mapara, Markus

AU - Radhakrishnan, Jai

AU - Maurer, Mathew S.

AU - Raza, Shahzad

AU - Mears, John G.

AU - Wall, Jonathan

AU - Solomon, Alan

AU - Lentzsch, Suzanne

PY - 2017/3/16

Y1 - 2017/3/16

UR - http://www.scopus.com/inward/record.url?scp=85018738564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018738564&partnerID=8YFLogxK

U2 - 10.1080/13506129.2017.1292900

DO - 10.1080/13506129.2017.1292900

M3 - Letter

C2 - 28434347

AN - SCOPUS:85018738564

VL - 24

SP - 58

EP - 59

JO - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

JF - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

SN - 1350-6129

ER -